BMY logo

BMY

Bristol-Myers Squibb Company

$47.18
+$0.30(+0.64%)
67
Overall
95
Value
40
Tech
--
Quality
Market Cap
$96.09B
Volume
10.69M
52W Range
$42.96 - $63.33
Target Price
$52.29
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$33.1B$38.9B$20.8B$22.6B$26.1B$42.5B$46.4B$46.2B$45.0B$48.3B
Total Revenue
$16.6B$19.4B$20.8B$22.6B$26.1B$42.5B$46.4B$46.2B$45.0B$48.3B
COST OF GOODS SOLD
Cost of Revenue
$3.9B$4.9B$6.1B$6.5B$8.1B$11.8B$9.9B$10.1B$10.7B$14.0B
GROSS PROFIT
Gross Profit
$12.7B$14.5B$14.7B$16.1B$18.1B$30.7B$36.4B$36.0B$34.3B$34.3B
OPERATING EXPENSES
Operating Expenses
$10.8B$9.9B$11.2B$10.9B$15.5B$18.8B$17.9B$26.9B$17.1B$19.6B
Research & Development
$5.9B$4.9B$6.5B$6.3B$6.1B$11.1B$10.2B$9.5B$9.3B$11.2B
Research Expense
$5.9B$4.9B$6.5B$6.3B$6.1B$11.1B$10.2B$9.5B$9.3B$11.2B
Selling, General & Administrative
$4.8B$4.9B$4.8B$4.6B$4.9B$7.7B$7.7B$7.8B$7.8B$8.4B
Selling & Marketing Expenses
$825.0M$789.0M$740.0M$672.0M$633.0M$990.0M$1.3B$1.3B$1.4B$1.5B
General & Administrative Expenses
$4.8B$4.9B$4.8B$4.6B$4.9B$7.7B$7.7B$7.8B$7.8B$8.4B
Salaries & Wages
$-77.0M$-69.0M$-59.0M$-41.0M$-87.0M$-158.0M$-120.0M$-91.0M$-105.0M$-108.0M
Depreciation & Amortization
$500.0M$448.0M$682.0M$505.0M$554.0M$586.0M$559.0M$587.0M$611.0M$651.0M
Depreciation & Amortization
$500.0M$448.0M$682.0M$505.0M$554.0M$586.0M$559.0M$587.0M$611.0M$651.0M
Amortization
$6.9B$6.9B$6.9B$6.5B$64.0B$53.3B$42.5B$35.9B$27.1B$23.3B
Other Operating Expenses
$-52.0M$-49.0M$-173.0M$-48.0M$-170.0M$-76.0M$-66.0M$-53.0M$-38.0M$-68.0M
OPERATING INCOME
Operating income
$18.4B$24.1B$3.4B$5.3B$21.8B$33.1B$29.7B$18.7B$17.2B$14.8B
EBITDA
$2.7B$6.4B$6.1B$6.8B$8.7B$4.9B$20.1B$19.2B$18.2B$20.0B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$184.0M$167.0M$196.0M$183.0M$656.0M$1.4B$1.3B$1.2B$1.2B--
Intinc
$101.0M$105.0M$126.0M$173.0M$464.0M$121.0M$39.0M$171.0M$449.0M$478.0M
Net Non-Operating Interest Income/Expense
$-83.0M$-62.0M$-70.0M$-10.0M$-192.0M$-1.3B$-1.3B$1.2B$449.0M$478.0M
Gain on Sale of Securities
--$-45.0M$23.0M$7.0M$275.0M$1.2B$745.0M$17.0M$3.0M$16.0M
Other Income/Expense
$-187.0M$-1.3B$-1.7B$-854.0M$938.0M$-2.3B$-720.0M$-159.0M$-1.2B$893.0M
Other Special Charges
$187.0M$1.3B$1.7B$854.0M$-938.0M$2.3B$720.0M$-576.0M$1.2B$-893.0M
SPECIAL ITEMS
Restructring And Mn A Income
$-15.0M$213.0M$-319.0M$4.1B$-3.4B$-10.0M$-19.0M$-7.0M$777.0M$1.1B
Special Income Charges
$-157.0M$-275.0M$806.0M$-4.2B$3.3B$183.0M$-63.0M$-171.0M$-387.0M$-1.2B
Impairment of Capital Assets
$13.0M$15.0M$241.0M$64.0M$15.0M$21.0M--------
PRE-TAX INCOME
EBIT
$2.1B$5.9B$5.1B$5.9B$5.2B$-5.5B$9.4B$8.9B$8.4B$9.7B
Pre-Tax Income
$2.1B$5.9B$5.1B$6.0B$5.0B$-6.9B$8.1B$7.7B$8.4B$-8.4B
INCOME TAX
Tax Provision
$446.0M$1.4B$4.2B$1.0B$1.5B$2.1B$1.1B$1.4B$400.0M$554.0M
NET INCOME
Net Income
$1.6B$4.5B$1.0B$4.9B$3.4B$-9.0B$7.0B$6.3B$8.0B$-8.9B
Net Income (Continuing Operations)
$1.6B$4.5B$1.0B$4.9B$3.4B$-9.0B$7.0B$6.3B$8.0B$-8.9B
Net Income (Discontinued Operations)
$1.6B$4.5B$1.0B$4.9B$3.4B$-9.0B$7.0B$6.3B$8.0B$-8.9B
Net Income (Common Stockholders)
$18.1B$23.9B$1.0B$10.1B$19.3B$-9.0B$7.0B$6.3B$8.0B$-8.9B
Normalized Income
$1.7B$4.2B$2.6B$-27.2B$-38.5B$-6.3B------$-3.9B
TOTALS
Total Expenses
$14.7B$14.8B$17.3B$17.4B$23.6B$30.6B$27.8B$37.1B$27.8B$33.5B
SHARE & EPS DATA
Average Shares Outstanding
$1.7B$1.7B$1.6B$1.6B$1.7B$2.3B$2.2B$2.1B$2.1B$2.0B
Average Shares Outstanding (Diluted)
$1.7B$1.7B$1.7B$1.6B$1.7B$2.3B$2.2B$2.1B$2.1B$2.0B
Shares Outstanding
$1.7B$1.7B$1.6B$1.6B$2.3B$2.2B$2.2B$2.1B$2.0B$2.0B
Basic EPS
$0.94$2.67$0.61$3.01$2.02$-3.99$3.15$2.97$3.88$-4.41
Basic EPS (Continuing Operations)
$0.94$2.67$0.61$3.01$2.02$-3.99$3.15$2.97$3.88$-4.41
Diluted EPS
$0.93$2.65$0.61$3.01$2.01$-3.99$3.12$2.95$3.86$-4.41
Diluted EPS (Continuing Operations)
$0.93$2.65$0.61$3.01$2.01$-3.99$3.12$2.95$3.86$-4.41
Dividend Per Share
$1.49$1.53$1.57$1.61$1.68$1.84$2.01$2.19$2.31$2.42
OTHER METRICS
Acquisition Expense
--------$657.0M----------
Commission Expenses
----------$24.4B--------
Earnings from equity interest
$83.0M$77.0M$75.0M$93.0M$-4.0M$72.0M$231.0M$-108.0M$-38.0M$44.0M
Earnings From Equity Interest Net Of Tax
$83.0M$77.0M$75.0M$93.0M$-4.0M$72.0M$231.0M$-108.0M$-38.0M$44.0M
Gains Loss On Disposal Of Discontinued Operations
$194.0M$564.0M$164.0M$178.0M$1.2B$55.0M$9.0M$211.0M--$-15.0M
Interest Expense Operating
$-205.0M$-191.0M$-215.0M$-218.0M$-414.0M$-1.6B$-1.5B$-1.4B$-1.2B$-1.8B
Marketing Expense
$825.0M$789.0M$740.0M$672.0M$633.0M$990.0M$1.3B$1.3B$1.4B$1.5B
Minority Interests
$-66.0M$-50.0M$32.0M$-27.0M$-21.0M$-20.0M$-20.0M$-18.0M$-15.0M--
Net Income Discontinuous Operations
$194.0M$564.0M$164.0M$178.0M$1.2B$55.0M$9.0M$211.0M--$-15.0M
Net Income Extraordinary
------$4.9B$3.5B----------
Non Recurring Operation Expense
$159.0M$47.0M$-487.0M$76.0M$77.0M$-194.0M$82.0M$178.0M$-390.0M$84.0M
Other Gand A
$4.8B$4.9B$4.8B$4.6B$4.9B$7.7B$7.7B$7.8B$7.8B$8.4B
Other Impairment Of Capital Assets
$181.0M$33.0M$80.0M$84.0M$-27.0M$1.1B$1.2B$101.0M$136.0M$2.9B
Other Taxes
--------$4.5B----------
Other Write Off
----$-3.0M--------------
Rent And Landing Fees
$140.0M$145.0M$120.0M$130.0M------------
Restruct
$-15.0M$213.0M$-319.0M$4.1B$-3.4B$-10.0M$-19.0M$-7.0M$777.0M$1.1B

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BMY$47.18+0.6%10.69M
3
4
5
6

Get Bristol-Myers Squibb Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.